FDA approves ripretinib for advanced gastrointestinal stromal tumour
The Food and Drug Administration (FDA) approved ripretinib, for adult patients with advanced gastrointestinal stromal…
Browsing: gastrointestinal stromal tumour
FDA approves avapritinib for gastrointestinal stromal tumour with a rare mutation
The Food and Drug Administration has approved avapritinib for adults with unresectable or metastatic gastrointestinal…